Baghdad study

kylejoesph11 | 4 points | Jun 19 2020 06:49:30

Baghdad study

The study was returned on the 16th, any updates on them publishing the data?

[-] fieldsofcoral | 5 points | Jun 19 2020 09:03:28

Hard to say exactly, but I think it means they sent it back to the researchers to correct some things. Otherwise if the review was all fine, it would have been released. Just my take, could be wrong.

[-] fyodor32768 | 5 points | Jun 19 2020 12:01:50

This is what the "help" option says.

The date on which the National Library of Medicine provided quality control (QC) review comments to the study sponsor or investigator. The sponsor or investigator must address major issues identified in the review comments. If there is a date listed for results returned after quality control review, but there is not a subsequent date listed for results submitted to ClinicalTrials.gov, this means that the submission is pending changes by the sponsor or investigator.

So it looks like it is still pending revisions and edits from reviewers.

[-] themanof68 | 5 points | Jun 19 2020 12:39:07

I believe it's better to be properly reviewed before publishing rather than be shot down by skeptics for minor issues.. Let them get it right

[-] nojox | 1 points | Jun 20 2020 20:18:14

I'd like to remind, as a layman, that we need at least 3-4 studies to be really confident.

The biggest thing going for ivermectin is that it is super cheap and super available and production can be scaled up easily.

So even if helps 25% cases or in particular stages only, that is still very effective. Like the recently announced dexamethasone (UK) - definitely, seriously helps reduce mortality even though it does not prevent or "cure" COVID.

Dosage, timing of intervention, genetics, age, viral load / severity all are important. So, feeling dejected if one study doesn't show promise is unwise. Other studies might work better.

In any case, it is best if the objective truth is published, rather than enthusiastic and biased conclusions.

So, wait for 3-4 proper reviewed studies. That means August/September, yes.

But after August, if ivermectin works for, hypothetically, even only 10-15% of cases, that's 10-15% of humanity out of trouble. That's still amazing because that 10-15% can go back to work with 2-4 cheap pills in their pocket and restart life and the economy. Have to wear masks, though!

Don't be disappointed if the results of any one study don't match the hype. Wait some more. It might help another demographic.

Edit: Remember also that masks and distancing are actually critical. They are as effective a preventive as any drug used so far.